BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 32517801)

  • 1. What scans we will read: imaging instrumentation trends in clinical oncology.
    Beyer T; Bidaut L; Dickson J; Kachelriess M; Kiessling F; Leitgeb R; Ma J; Shiyam Sundar LK; Theek B; Mawlawi O
    Cancer Imaging; 2020 Jun; 20(1):38. PubMed ID: 32517801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentials and caveats of AI in hybrid imaging.
    Shiyam Sundar LK; Muzik O; Buvat I; Bidaut L; Beyer T
    Methods; 2021 Apr; 188():4-19. PubMed ID: 33068741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Artificial intelligence in hybrid imaging].
    Strack C; Seifert R; Kleesiek J
    Radiologe; 2020 May; 60(5):405-412. PubMed ID: 32052114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PET in the 2020s: a roadmap.
    Meikle SR; Sossi V; Roncali E; Cherry SR; Banati R; Mankoff D; Jones T; James M; Sutcliffe J; Ouyang J; Petibon Y; Ma C; El Fakhri G; Surti S; Karp JS; Badawi RD; Yamaya T; Akamatsu G; Schramm G; Rezaei A; Nuyts J; Fulton R; Kyme A; Lois C; Sari H; Price J; Boellaard R; Jeraj R; Bailey DL; Eslick E; Willowson KP; Dutta J
    Phys Med Biol; 2021 Mar; 66(6):06RM01. PubMed ID: 33339012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of multi-modality PET and MR imaging in abdominal oncology.
    Min LA; Castagnoli F; Vogel WV; Vellenga JP; van Griethuysen JJM; Lahaye MJ; Maas M; Beets Tan RGH; Lambregts DMJ
    Br J Radiol; 2021 Oct; 94(1126):20201351. PubMed ID: 34387508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images.
    Zaharchuk G; Davidzon G
    Semin Nucl Med; 2021 Mar; 51(2):134-142. PubMed ID: 33509370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vision 20/20: Simultaneous CT-MRI--Next chapter of multimodality imaging.
    Wang G; Kalra M; Murugan V; Xi Y; Gjesteby L; Getzin M; Yang Q; Cong W; Vannier M
    Med Phys; 2015 Oct; 42(10):5879-89. PubMed ID: 26429262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical PET/MR Imaging in Oncology: Future Perspectives.
    Kjær A; Torigian DA
    PET Clin; 2016 Oct; 11(4):489-93. PubMed ID: 27593252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence in Oncological Hybrid Imaging.
    Feuerecker B; Heimer MM; Geyer T; Fabritius MP; Gu S; Schachtner B; Beyer L; Ricke J; Gatidis S; Ingrisch M; Cyran CC
    Rofo; 2023 Feb; 195(2):105-114. PubMed ID: 36170852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives.
    Seifert R; Weber M; Kocakavuk E; Rischpler C; Kersting D
    Semin Nucl Med; 2021 Mar; 51(2):170-177. PubMed ID: 33509373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GOSTT concept and hybrid mixed/virtual/augmented reality environment radioguided surgery.
    Valdés Olmos RA; Vidal-Sicart S; Giammarile F; Zaknun JJ; Van Leeuwen FW; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):207-15. PubMed ID: 24835294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.
    Bernsen MR; Vaissier PE; Van Holen R; Booij J; Beekman FJ; de Jong M
    Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1(Suppl 1):S36-49. PubMed ID: 24895751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.